Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, January 25 '25)

Image
By G.M.

 


    Antiviral Res

  1. XU M, Zhang Z, Sun Y, Mai H, et al
    IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility.
    Antiviral Res. 2025 Jan 17:106082. doi: 10.1016/j.antiviral.2025.106082.
    PubMed         Abstract available

  2. CHUTIWITOONCHAI N, Akkarawongsapat R, Chantawarin S, Jiarpinitnun C, et al
    Antiviral effect of pinostrobin, a bioactive constituent of Boesenbergia rotunda, against porcine epidemic diarrhea virus.
    Antiviral Res. 2025;234:106073.
    PubMed         Abstract available


    BMJ

  3. AGIUS RM
    Healthcare workers should get covid-19 vaccinations.
    BMJ. 2025;388:r89.
    PubMed        


    Graefes Arch Clin Exp Ophthalmol

  4. KIM W, Park CM, Choi YJ, Kim DH, et al
    Recent trends and outcomes in immediate and delayed sequential bilateral cataract surgeries: a nationwide cohort study in South Korea.
    Graefes Arch Clin Exp Ophthalmol. 2025 Jan 20. doi: 10.1007/s00417-025-06737.
    PubMed         Abstract available


    Int J Infect Dis

  5. RICCIO MD, Caini S
    Refining Influenza Epidemiology in the Post-COVID-19 Era: The Need for Complementary Approaches.
    Int J Infect Dis. 2025 Jan 18:107787. doi: 10.1016/j.ijid.2025.107787.
    PubMed        


    J Infect

  6. SILVA SOUZA M, Pires Farias J, de Souza Ferreira LC, Amorim JH, et al
    Declining COVID-19 vaccination coverage in Brazil: A global health warning.
    J Infect. 2025;90:106418.
    PubMed        

  7. FENG S, Bibi S, Aley PK, Cappuccini F, et al
    Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
    J Infect. 2025;90:106423.
    PubMed         Abstract available


    J Med Virol

  8. SOLAR P, Sery O, Vojtisek T, Krajsa J, et al
    The Blood-Cerebrospinal Fluid Barrier as a Potential Entry Site for the SARS-CoV-2 Virus.
    J Med Virol. 2025;97:e70184.
    PubMed         Abstract available


    J Virol

  9. CHEN R, Zhou G, Yang J, Yuan R, et al
    A novel neutralizing antibody recognizing a conserved conformational epitope in PDCoV S1 protein and its therapeutic efficacy in piglets.
    J Virol. 2025 Jan 22:e0202524. doi: 10.1128/jvi.02025.
    PubMed         Abstract available

  10. HASEGAWA N, Nishimura M, Takamiya R, Ishimaru H, et al
    SARS-CoV-2 BA.2.86 is susceptible to the neutralizing antibody MO11 targeting subdomain 1 despite the E554K mutation near the epitope.
    J Virol. 2025 Jan 22:e0138924. doi: 10.1128/jvi.01389.
    PubMed        

  11. LIANG R, Tian J, Liu K, Ma L, et al
    The cytoplasmic tail of IBV spike mediates intracellular retention via interaction with COPI-coated vesicles in retrograde trafficking.
    J Virol. 2025 Jan 22:e0216424. doi: 10.1128/jvi.02164.
    PubMed         Abstract available


    Life Sci

  12. DE SOUZA ALG, da Silva Rosa Alves AL, de Sousa JC, Barbosa NC, et al
    Inactivated SARS-CoV-2 induces acute skeletal muscle damage in human K18-hACE2 transgenic mice.
    Life Sci. 2025 Jan 18:123404. doi: 10.1016/j.lfs.2025.123404.
    PubMed         Abstract available


    Travel Med Infect Dis

  13. ALBY A, Power A, Flaherty GT
    Analysis of consular assistance provided to Irish citizens abroad, 2014-2023.
    Travel Med Infect Dis. 2025 Jan 20:102803. doi: 10.1016/j.tmaid.2025.102803.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »